Interim Chief Science Officer, Alzheimer's Drug Discovery Foundation
Appears in 1 story
Independent voice assessing the field
For decades, nearly every Alzheimer's drug that reached patients aimed at one target: a sticky protein called amyloid. On July 14, 2026, Biogen showed the first clinical evidence that hitting a different protein, tau, can also slow the disease.
Updated Jul 14
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
